Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

V3.2, a family of open-source reasoning and agentic AI models. The high compute version, DeepSeek-V3.2-Speciale, performs ...

Cathie Wood’s trades often read like a quiet manifesto – what she buys signals confidence, what she trims hints at fading faith. In the week ended Dec. 19, that message was clear. ARK Investment ...

Ms. Gay writes about politics for Opinion. She reported from New Orleans. Mr. Winter is a staff photographer on assignment for Opinion. Dec. 21, 2025 At a New Orleans Hilton along the banks of the ...

For decades, Broadway has welcomed film and TV's biggest stars as they headed to New York City for the chance to share in the intimate experience of performing in front of a live audience. This ...

Are you a fan of high-quality audio but don't want to put anything in your ears? These are our favorite on-ear and over-ear headphones. I've been a contributing editor for PCMag since 2011. Before ...

One analyst tracking the biotech upgraded her recommendation on its shares. She now believes that they rate a buy, rather than a hold.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.